Peptide directoryGut, pancreas & liver

Uroguanylin

Guanylin’s cousin that works in acid, and plecanatide’s model.

Related medicinesPlecanatideLinaclotide

Where it comes from

Made in
Enterochromaffin cells of the duodenum and small intestine; also found in urine
Sent out by
After salty meals; it works in the acid duodenum where guanylin does not
Acts on
  • Small-intestinal epithelium
  • Kidney (sodium excretion)
  • Hypothalamus (satiety, in mice)

What it does

  • Secretes fluid and bicarbonate in the upper gut 1
  • Tells the kidney to shed sodium after a salty meal 1
  • Signals fullness in mice; not confirmed in people 3

In medicine

  • Plecanatide is uroguanylin with one amino acid changed, approved for chronic constipation and IBS with constipation 2
  • No clinical test measures it; the assays are difficult because the peptide is small, bridged and present in tiny amounts 1

Beyond the body’s own use

  • Its satiety role came from mice, where uroguanylin made in the gut reached the hypothalamus and cut food intake, and where deleting the receptor made the animals eat more 3. No human data followed and no obesity medicine came of it
  • Low uroguanylin is reported in obesity, which would fit that story, but the measurements are hard and nothing shows which way the cause runs 1

Sources

  1. Forte, Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics, Pharmacology and Therapeutics 2004
  2. Plecanatide (Trulance), FDA application NDA 208745
  3. Valentino et al., A uroguanylin-GUCY2C endocrine axis regulates feeding in mice, Journal of Clinical Investigation 2011

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.